LINC01322: A Long RNA Candidate for Gene Expression Regulation and Potential Drug Targets

Target Name: LINC01322

NCBI ID: G103695433

LINC01322

Other Name(s): long intergenic non-protein coding RNA 1322 | Long intergenic non-protein coding RNA 1322 | RUS

LINC01322: A Long RNA Candidate for Gene Expression Regulation and Potential Drug Targets

LINC01322 is a long intergenic non-protein coding RNA (lncRNA) with a length of approximately 290 nucleotides. It is located within intron 9 of the human chromosome 22. LINC01322 is a non-coding RNA which means it does not have a protein coding gene associated with it.

LINC01322 is characterized by its unique structure and its location in the genome. It is a long RNA molecule that contains a unique five-carbon sugar coding sequence, which is not found in any other lncRNA. Additionally, LINC01322 is located in a region of the genome that is highly conserved, which suggests that it is an important gene candidate.

The function of LINC01322 is still not well understood, but it is possible that it plays a role in the regulation of gene expression. This is because LINC01322 is highly expressed in many tissues and cells, and it is found in a variety of gene expression profiles.

One potential drug target for LINC01322 is the use of small molecules to modulate its expression. This could be done by binding to specific sequences within the lncRNA, which would cause it to be degraded or translated into a protein.

Another potential drug target for LINC01322 is the use of RNA interference (RNAi) technology. RNAi is a technique that uses small interfering RNA (siRNA) to knockdown the expression of specific genes. This could be done by using siRNA to target the lncRNA, which would cause it to be degraded.

In conclusion, LINC01322 is a unique and promising lncRNA that is characterized by its long length, unique structure, and its location in the genome. Further research is needed to fully understand its function and potential drug targets.

Protein Name: Long Intergenic Non-protein Coding RNA 1322

The "LINC01322 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC01322 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets